• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Journal articles
    • View Item
    • Home
    • Griffith Research Online
    • Journal articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • Financial Toxicity Among Patients With Cancer-Where to From Here? (Editorial)

    Thumbnail
    View/Open
    Chan174863-Accepted.pdf (34.14Kb)
    File version
    Accepted Manuscript (AM)
    Author(s)
    Gordon, Louisa G
    Chan, Raymond Javan
    Griffith University Author(s)
    Chan, Ray
    Year published
    2017
    Metadata
    Show full item record
    Abstract
    In oncology, the term “financial toxicity” means the financial hardship or financial burden for patients and families that arise from cancer treatment and ongoing expenses. Individuals from any socioeconomic group may experience this, and it can occur in both low- and high-income countries. There are 2 key contributors: (1) high medical payments by individuals/households and (2) reduced income while being treated or recovering from cancer. The former is likely to affect more individuals in high-income countries, whereas the latter is more problematic in poor households although, clearly, individuals will be worse when faced ...
    View more >
    In oncology, the term “financial toxicity” means the financial hardship or financial burden for patients and families that arise from cancer treatment and ongoing expenses. Individuals from any socioeconomic group may experience this, and it can occur in both low- and high-income countries. There are 2 key contributors: (1) high medical payments by individuals/households and (2) reduced income while being treated or recovering from cancer. The former is likely to affect more individuals in high-income countries, whereas the latter is more problematic in poor households although, clearly, individuals will be worse when faced with both high out-of-pocket medical expenses (outgoings) and concurrent loss of earnings (incomings). In some studies, financial hardship is defined as spending greater than 30% of household income on healthcare and is termed “catastrophic spending.”1
    View less >
    Journal Title
    Cancer Nursing
    Volume
    40
    Issue
    4
    DOI
    https://doi.org/10.1097/NCC.0000000000000510
    Copyright Statement
    © 2017 Lippincott Williams & Wilkins. This is a non-final version of an article published in final form in Cancer Nursing, 2017, 40 (4), pp. 257-258. Reproduced in accordance with the copyright policy of the publisher. Please refer to the journal link for access to the definitive, published version.
    Subject
    Nursing
    Oncology and carcinogenesis
    Science & Technology
    Life Sciences & Biomedicine
    COST
    Publication URI
    http://hdl.handle.net/10072/396415
    Collection
    • Journal articles

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E
    • TEQSA: PRV12076

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander